Patents/Inventors

Xiaozhang Zheng

Lexington, MAUS32 patents

28 Patents

US126065682026
SMARCA Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125584272026
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125515642026
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125456592026
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US125287852026
MDM2 Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US124798072025
Methods Using HDAC11 Inhibitors
VALO HEALTH, Inc.
0 cites
US123369812025
Compounds and Compositions for the Inhibition of NAMPT
Genentech, Inc.
0 cites
US123049042025
Bicyclic [4,6,0] Hydroxamic Acids as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US122641372025
3-aryl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US122583412025
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US122139692025
2-spiro-5- and 6-hydroxamic Acid Indanes as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US121509952024
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US121227782024
Activating Pyruvate Kinase R
Novo Nordisk Health Care AG
0 cites
US120972612024
CDK2 Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US120914112024
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US120714402024
Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators
Novo Nordisk Health Care AG
0 cites
US120534582024
Treating Sickle Cell Disease with a Pyruvate Kinase R Activating Compound
Novo Nordisk Health Care AG
0 cites
US119806112024
Treating Sickle Cell Disease with a Pyruvate Kinase R Activating Compound
Novo Nordisk Health Care AG
0 cites
US119326242024
MDM2 Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US119198392024
Alpha-cinnamide Compounds and Compositions as HDAC8 Inhibitors
VALO HEALTH, Inc.
0 cites
US118913652024
3-alkyl-4-amido-bicyclic [4,5,0] Hydroxamic Acids as HDAC Inhibitors
VALO HEALTH, Inc.
0 cites
US118076362023
IRAK Degraders and Uses Thereof
Kymera Therapeutics, Inc.
0 cites
US117307212023
2-spiro-5- and 6-hydroxamic Acid Indanes as HDAC Inhibitors
Valo Health, Inc.
0 cites
US117024122023
Bicyclic [4,6,0] Hydroxamic Acids as HDAC Inhibitors
Valo Health, Inc.
0 cites
US116857502023
Crystalline Forms of IRAK Degraders
Kymera Therapeutics, Inc.
0 cites
US116492422023
Pyrrolopyrrole Compositions as Pyruvate Kinase (PKR) Activators
FORMA THERAPEUTICS, Inc.
0 cites
US115913322023
IRAK Degraders and Uses Thereof
KYMERA THERAPEUTICS, Inc.
0 cites
US115477012023
Compounds and Compositions for the Inhibition of NAMPT
Genentech, Inc.
0 cites